in | 6M20 | 6M19 | |||
Consolidated statements of operations (CHF million) | |||||
Interest and dividend income |
|
|
|||
Interest expense |
( |
( |
|||
Net interest income |
|
|
|||
Commissions and fees |
|
|
|||
Trading revenues |
|
|
|||
Other revenues |
|
|
|||
Net revenues |
|
|
|||
Provision for credit losses |
|
|
|||
Compensation and benefits |
|
|
|||
General and administrative expenses |
|
|
|||
Commission expenses |
|
|
|||
Total other operating expenses |
|
|
|||
Total operating expenses |
|
|
|||
Income before taxes |
|
|
|||
Income tax expense |
|
|
|||
Net income |
|
|
|||
Net income attributable to noncontrolling interests |
|
|
|||
Net income attributable to shareholders |
|
|
in | 6M20 | 6M19 | |||
Comprehensive income/(loss) (CHF million) | |||||
Net income |
|
|
|||
Gains/(losses) on cash flow hedges |
|
|
|||
Foreign currency translation |
( |
( |
|||
Unrealized gains/(losses) on securities |
( |
|
|||
Actuarial gains/(losses) |
|
|
|||
Gains/(losses) on liabilities related to credit risk |
|
( |
|||
Other comprehensive income/(loss), net of tax |
|
( |
|||
Comprehensive income |
|
|
|||
Comprehensive income/(loss) attributable to noncontrolling interests |
( |
|
|||
Comprehensive income attributable to shareholders |
|
|
end of | 6M20 | 2019 | |||
Assets (CHF million) | |||||
Cash and due from banks |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Interest-bearing deposits with banks |
|
|
|||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|||
of which reported at fair value |
|
|
|||
Securities received as collateral, at fair value |
|
|
|||
of which encumbered |
|
|
|||
Trading assets, at fair value |
|
|
|||
of which encumbered |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Investment securities |
|
|
|||
of which reported at fair value |
|
|
|||
of which encumbered |
|
|
|||
Other investments |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Net loans |
|
|
|||
of which reported at fair value |
|
|
|||
of which encumbered |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
allowance for loan losses |
( |
( |
|||
Goodwill |
|
|
|||
Other intangible assets |
|
|
|||
of which reported at fair value |
|
|
|||
Brokerage receivables |
|
|
|||
Other assets |
|
|
|||
of which reported at fair value |
|
|
|||
of which encumbered |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
of which loans held-for-sale reported at lower of cost and market value (amortized cost base) |
|
– | |||
Total assets |
|
|
end of | 6M20 | 2019 | |||
Liabilities and equity (CHF million) | |||||
Due to banks |
|
|
|||
of which reported at fair value |
|
|
|||
Customer deposits |
|
|
|||
of which reported at fair value |
|
|
|||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|||
of which reported at fair value |
|
|
|||
Obligation to return securities received as collateral, at fair value |
|
|
|||
Trading liabilities, at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Short-term borrowings |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Long-term debt |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Brokerage payables |
|
|
|||
Other liabilities |
|
|
|||
of which reported at fair value |
|
|
|||
of which reported from consolidated VIEs |
|
|
|||
Total liabilities |
|
|
|||
Common shares |
|
|
|||
Additional paid-in capital |
|
|
|||
Retained earnings |
|
|
|||
Accumulated other comprehensive income/(loss) |
( |
( |
|||
Total shareholders' equity |
|
|
|||
Noncontrolling interests |
|
|
|||
Total equity |
|
|
|||
Total liabilities and equity |
|
|
end of | 6M20 | 2019 | |||
Additional share information | |||||
Par value (CHF) |
|
|
|||
Issued shares |
|
|
|||
Shares outstanding |
|
|
|||
|
Attributable to shareholders | |||||||||||||||||
Common shares |
Additional paid-in capital |
Retained earnings |
Treasury shares, at cost |
1 |
AOCI |
Total
share- holders' equity |
Non- controlling interests |
Total equity |
|||||||||
6M20 (CHF million) | |||||||||||||||||
Balance at beginning of period |
|
|
|
|
( |
|
|
|
|||||||||
Purchase of subsidiary shares from non- controlling interests, not changing ownership 2, 3 | – | – | – | – | – | – |
( |
( |
|||||||||
Sale of subsidiary shares to noncontrolling interests, not changing ownership 3 | – | – | – | – | – | – |
|
|
|||||||||
Net income/(loss) | – | – |
|
– | – |
|
|
|
|||||||||
Cumulative effect of accounting changes, net of tax | – | – |
( |
– | – |
( |
– |
( |
|||||||||
Total other comprehensive income/(loss), net of tax | – | – | – | – |
|
|
( |
|
|||||||||
Share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends on share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends paid | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Changes in scope of consolidation, net | – | – | – | – | – | – |
|
|
|||||||||
Other | – |
|
– | – | – |
|
|
|
|||||||||
Balance at end of period |
|
|
|
|
( |
|
|
|
|||||||||
6M19 (CHF million) | |||||||||||||||||
Balance at beginning of period |
|
|
|
|
( |
|
|
|
|||||||||
Purchase of subsidiary shares from non- controlling interests, not changing ownership | – | – | – | – | – | – |
( |
( |
|||||||||
Sale of subsidiary shares to noncontrolling interests, not changing ownership | – | – | – | – | – | – |
|
|
|||||||||
Net income/(loss) | – | – |
|
– | – |
|
|
|
|||||||||
Cumulative effect of accounting changes, net of tax | – | – |
|
– |
( |
|
– |
|
|||||||||
Total other comprehensive income/(loss), net of tax | – | – | – | – |
( |
( |
( |
( |
|||||||||
Share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends on share-based compensation, net of tax | – |
( |
– | – | – |
( |
– |
( |
|||||||||
Dividends paid | – | – |
( |
– | – |
( |
( |
( |
|||||||||
Changes in scope of consolidation, net | – | – | – | – | – | – |
|
|
|||||||||
Other | – |
( |
– | – | – |
( |
|
( |
|||||||||
Balance at end of period |
|
|
|
|
( |
|
|
|
|||||||||
1
|
|||||||||||||||||
2
|
|||||||||||||||||
3
|
in | 6M20 | 6M19 | |||
Operating activities (CHF million) | |||||
Net income |
|
|
|||
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities (CHF million) | |||||
Impairment, depreciation and amortization |
|
|
|||
Provision for credit losses |
|
|
|||
Deferred tax provision/(benefit) |
|
|
|||
Valuation adjustments relating to long-term debt |
|
|
|||
Share of net income/(loss) from equity method investments |
( |
( |
|||
Trading assets and liabilities, net |
|
( |
|||
(Increase)/decrease in other assets |
( |
( |
|||
Increase/(decrease) in other liabilities |
|
|
|||
Other, net |
( |
( |
|||
Total adjustments |
( |
( |
|||
Net cash provided by/(used in) operating activities |
( |
( |
|||
Investing activities (CHF million) | |||||
(Increase)/decrease in interest-bearing deposits with banks |
( |
|
|||
(Increase)/decrease in central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
( |
|
|||
Purchase of investment securities |
( |
( |
|||
Proceeds from sale of investment securities |
|
|
|||
Maturities of investment securities |
|
|
|||
Investments in subsidiaries and other investments |
( |
( |
|||
Proceeds from sale of other investments |
|
|
|||
(Increase)/decrease in loans |
( |
( |
|||
Proceeds from sales of loans |
|
|
|||
Capital expenditures for premises and equipment and other intangible assets |
( |
( |
|||
Proceeds from sale of premises and equipment and other intangible assets |
|
|
|||
Other, net |
|
|
|||
Net cash provided by/(used in) investing activities |
( |
( |
in | 6M20 | 6M19 | |||
Financing activities (CHF million) | |||||
Increase/(decrease) in due to banks and customer deposits |
|
|
|||
Increase/(decrease) in short-term borrowings |
|
|
|||
Increase/(decrease) in central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
( |
|||
Issuances of long-term debt |
|
|
|||
Repayments of long-term debt |
( |
( |
|||
Dividends paid |
( |
( |
|||
Other, net |
|
|
|||
Net cash provided by/(used in) financing activities |
|
|
|||
Effect of exchange rate changes on cash and due from banks (CHF million) | |||||
Effect of exchange rate changes on cash and due from banks |
( |
( |
|||
Net increase/(decrease) in cash and due from banks (CHF million) | |||||
Net increase/(decrease) in cash and due from banks |
|
( |
|||
Cash and due from banks at beginning of period 1 |
|
|
|||
Cash and due from banks at end of period 1 |
|
|
|||
1
|
in | 6M20 | 6M19 | |||
Cash paid for income taxes and interest (CHF million) | |||||
Cash paid for income taxes |
|
|
|||
Cash paid for interest |
|
|
in | 6M20 | 6M19 | |||
Net revenues (CHF million) | |||||
Swiss Universal Bank |
|
|
|||
International Wealth Management |
|
|
|||
Asia Pacific |
|
|
|||
Global Markets |
|
|
|||
Investment Banking & Capital Markets |
|
|
|||
Adjustments |
( |
( |
|||
Net revenues |
|
|
|||
Income/(loss) before taxes (CHF million) | |||||
Swiss Universal Bank |
|
|
|||
International Wealth Management |
|
|
|||
Asia Pacific |
|
|
|||
Global Markets |
|
|
|||
Investment Banking & Capital Markets |
( |
( |
|||
Adjustments 1 |
( |
( |
|||
Income/(loss) before taxes |
|
|
|||
1
Adjustments represent certain consolidating entries and balances, including those
relating to items that are managed but are not legally owned by the Bank and vice
versa, and certain revenues and expenses that were not allocated to the segments,
including such items relating to the Asset Resolution Unit.
|
end of | 6M20 | 2019 | |||
Total assets (CHF million) | |||||
Swiss Universal Bank |
|
|
|||
International Wealth Management |
|
|
|||
Asia Pacific |
|
|
|||
Global Markets |
|
|
|||
Investment Banking & Capital Markets |
|
|
|||
Adjustments 1 |
|
|
|||
Total assets |
|
|
|||
1
Adjustments represent certain consolidating entries and balances, including those
relating to items that are managed but are not legally owned by the Bank and vice
versa, and certain revenues and expenses that were not allocated to the segments,
including such items relating to the Asset Resolution Unit.
|
in | 6M20 | 6M19 | |||
Net interest income (CHF million) | |||||
Loans |
|
|
|||
Investment securities |
|
|
|||
Trading assets |
|
|
|||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|||
Other |
|
|
|||
Interest and dividend income |
|
|
|||
Deposits |
( |
( |
|||
Short-term borrowings |
( |
( |
|||
Trading liabilities |
( |
( |
|||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
( |
( |
|||
Long-term debt |
( |
( |
|||
Other |
( |
( |
|||
Interest expense |
( |
( |
|||
Net interest income |
|
|
in | 6M20 | 6M19 | |||
Commissions and fees (CHF million) | |||||
Lending business |
|
|
|||
Investment and portfolio management |
|
|
|||
Other securities business |
|
|
|||
Fiduciary business |
|
|
|||
Underwriting |
|
|
|||
Brokerage |
|
|
|||
Underwriting and brokerage |
|
|
|||
Other services |
|
|
|||
Commissions and fees |
|
|
in | 6M20 | 6M19 | |||
Trading revenues (CHF million) | |||||
Interest rate products |
( |
|
|||
Foreign exchange products |
|
( |
|||
Equity/index-related products |
( |
|
|||
Credit products |
|
( |
|||
Commodity and energy products |
|
|
|||
Other products |
|
|
|||
Trading revenues |
|
|
|||
Represents revenues on a product basis which are not representative of business results
within segments, as segment results utilize financial instruments across various product
types.
|
in | 6M20 | 6M19 | |||
Other revenues (CHF million) | |||||
Loans held-for-sale |
( |
( |
|||
Long-lived assets held-for-sale |
|
|
|||
Equity method investments |
|
|
|||
Other investments |
|
|
|||
Other |
|
|
|||
Other revenues |
|
|
in | 6M20 | 6M19 | |||
Provision for credit losses (CHF million) | |||||
Loans held at amortized cost |
|
|
|||
Other financial assets held at amortized cost |
|
|
|||
Off-balance sheet credit exposures |
|
|
|||
Provision for credit losses |
|
|
in | 6M20 | 6M19 | |||
Compensation and benefits (CHF million) | |||||
Salaries and variable compensation |
|
|
|||
Social security |
|
|
|||
Other |
|
1 |
|
||
Compensation and benefits |
|
|
|||
1
Includes pension-related expenses of CHF
|
in | 6M20 | 6M19 | |||
General and administrative expenses (CHF million) | |||||
Occupancy expenses |
|
|
|||
IT, machinery and equipment |
|
|
|||
Provisions and losses |
|
|
|||
Travel and entertainment |
|
|
|||
Professional services |
|
|
|||
Amortization and impairment of other intangible assets |
|
|
|||
Other 1 |
|
|
|||
General and administrative expenses |
|
|
|||
1
Includes pension-related expenses/(credits) of CHF
|
in | 6M20 | 6M19 | |||
Contracts with customers (CHF million) | |||||
Investment and portfolio management |
|
|
|||
Other securities business |
|
|
|||
Underwriting |
|
|
|||
Brokerage |
|
|
|||
Other services |
|
|
|||
Total revenues from contracts with customers |
|
|
end of | 2Q20 | 1Q20 | 4Q19 | ||||
Contract balances (CHF million) | |||||||
Contract receivables |
|
|
|
||||
Contract liabilities |
|
|
|
||||
Revenue recognized in the reporting period included in the contract liabilities balance at the beginning of period |
|
|
|
end of | 6M20 | 2019 | |||
Trading assets (CHF million) | |||||
Debt securities |
|
|
|||
Equity securities |
|
|
|||
Derivative instruments 1 |
|
|
|||
Other |
|
|
|||
Trading assets |
|
|
|||
Trading liabilities (CHF million) | |||||
Short positions |
|
|
|||
Derivative instruments 1 |
|
|
|||
Trading liabilities |
|
|
|||
1
Amounts shown after counterparty and cash collateral netting.
|
end of | 6M20 | 2019 | |||
Cash collateral on derivative instruments – netted (CHF million) 1 | |||||
Cash collateral paid |
|
|
|||
Cash collateral received |
|
|
|||
Cash collateral on derivative instruments – not netted (CHF million) 2 | |||||
Cash collateral paid |
|
|
|||
Cash collateral received |
|
|
|||
1
Recorded as cash collateral netting on derivative instruments in Note 22 – Offsetting
of financial assets and financial liabilities.
|
|||||
2
Recorded as cash collateral on derivative instruments in Note 19 – Other assets and
other liabilities.
|
end of | 6M20 | 2019 | |||
Investment securities (CHF million) | |||||
Debt securities held-to-maturity |
|
|
|||
Debt securities available-for-sale |
|
|
|||
Total investment securities |
|
|
6M20 | 2019 | ||||||||||||||||
end of |
Amortized cost |
Gross
unrealized gains |
Gross
unrealized losses |
Fair value |
Amortized cost |
Gross
unrealized gains |
Gross
unrealized losses |
Fair value |
|||||||||
Investment securities by type (CHF million) | |||||||||||||||||
Corporate debt securities |
|
|
|
|
|
|
|
|
|||||||||
Debt securities held-to-maturity |
|
|
|
|
|
|
|
|
|||||||||
Foreign governments |
|
|
|
|
|
|
|
|
|||||||||
Corporate debt securities |
|
|
|
|
|
|
|
|
|||||||||
Debt securities available-for-sale |
|
|
|
|
|
|
|
|
Less than 12 months | 12 months or more | Total | |||||||||||
end of |
Fair value |
Gross
unrealized losses |
Fair value |
Gross
unrealized losses |
Fair value |
Gross
unrealized losses |
|||||||
2019 (CHF million) | |||||||||||||
Corporate debt securities |
|
|
|
|
|
|
|||||||
Debt securities available-for-sale |
|
|
|
|
|
|
in | 6M20 | 6M19 | |||
Sales of debt securities available-for-sale (CHF million) | |||||
Proceeds from sales |
|
|
|||
Realized gains |
|
|
end of 6M20 |
Amortized cost |
Fair value |
Average
yield (in %) |
||||
CHF million, except where indicated | |||||||
Due within 1 year |
|
|
|
||||
Debt securities held-to-maturity |
|
|
|
Due within 1 year |
|
|
|
||||
Due from 5 to 10 years |
|
|
|
||||
Debt securities available-for-sale |
|
|
|
end of | 6M20 | 2019 | |||
Other investments (CHF million) | |||||
Equity method investments |
|
|
|||
Equity securities (without a readily determinable fair value) 1 |
|
|
|||
of which at net asset value |
|
|
|||
of which at measurement alternative |
|
|
|||
of which at fair value |
|
|
|||
of which at cost less impairment |
|
|
|||
Real estate held-for-investment 2 |
|
|
|||
Life finance instruments 3 |
|
|
|||
Total other investments |
|
|
|||
1
Includes private equity, hedge funds and restricted stock investments as well as certain
investments in non-marketable mutual funds for which the Bank has neither significant
influence nor control over the investee.
|
|||||
2
As of the end of 6M20 and 2019, real estate held for investment included foreclosed
or repossessed real estate of CHF
|
|||||
3
Includes single premium immediate annuity contracts.
|
in / end of | 6M20 | Cumulative | 6M19 | ||||
Impairments and adjustments (CHF million) | |||||||
Impairments and downward adjustments |
( |
( |
|
||||
Upward adjustments |
|
|
|
end of | 6M20 | 2019 | |||
Loans (CHF million) | |||||
Mortgages 1 |
|
|
|||
Loans collateralized by securities 1 |
|
|
|||
Consumer finance |
|
|
|||
Consumer |
|
|
|||
Real estate |
|
|
|||
Commercial and industrial loans 1 |
|
|
|||
Financial institutions |
|
|
|||
Governments and public institutions |
|
|
|||
Corporate & institutional |
|
|
|||
Gross loans |
|
|
|||
of which held at amortized cost |
|
|
|||
of which held at fair value |
|
|
|||
Net (unearned income)/deferred expenses |
( |
( |
|||
Allowance for credit losses |
( |
( |
|||
Net loans |
|
|
|||
Gross loans by location | |||||
Switzerland |
|
|
|||
Foreign |
|
|
|||
Gross loans |
|
|
|||
Impaired loans | |||||
Non-performing loans |
|
|
|||
Non-interest-earning loans |
|
|
|||
Non-accrual loans |
|
|
|||
Restructured loans |
|
|
|||
Potential problem loans |
|
|
|||
Other impaired loans |
|
|
|||
Gross impaired loans 2 |
|
|
|||
1
Certain corporate & institutional loans have been reclassified to consumer loans following
the application of a look-through approach with regard to beneficial owners. Prior
periods have been reclassified to conform to the current presentation.
|
|||||
2
As of the end of 6M20 and 2019, CHF
|
end of |
Amortized cost basis |
1 |
Allowance
for credit losses |
Net
carrying value |
|||
6M20 (CHF million) | |||||||
Cash and due from banks |
|
( |
|
||||
Interest-bearing deposits with banks |
|
2 |
( |
|
|||
Securities purchased under resale agreements and securities borrowing transactions |
|
|
|
||||
Debt securities held-to-maturity |
|
|
|
||||
Loans |
|
2,3 |
( |
|
|||
Brokerage receivables |
|
2 |
|
|
|||
Other assets |
|
( |
|
||||
Total |
|
( |
|
||||
1
Net of unearned income/deferred expenses, as applicable.
|
|||||||
2
Excludes accrued interest for credit losses in the total amount of CHF 490 million,
with no related allowance for credit losses. Of the accrued interest balance, CHF
2 million relates to interest-bearing deposits with banks, CHF 453 million to loans
and CHF 35 million to brokerage receivables. These accrued interest balances are reported
in other assets.
|
|||||||
3
Includes endangered interest of CHF
|
6M20 | 6M19 | 1 | |||||||||||
Consumer |
Corporate &
institutional |
Total |
Consumer |
Corporate &
institutional |
Total |
||||||||
Allowance for credit losses (CHF million) | |||||||||||||
Balance at beginning of period |
|
|
|
2 |
|
|
|
||||||
Current-period provision for expected credit losses |
|
|
|
|
|
|
|||||||
of which provisions for interest 3 |
|
|
|
– | – | – | |||||||
Gross write-offs |
( |
( |
( |
( |
( |
( |
|||||||
Recoveries |
|
|
|
|
|
|
|||||||
Net write-offs |
( |
( |
( |
( |
( |
( |
|||||||
Provisions for interest | – | – | – |
|
|
|
|||||||
Foreign currency translation impact and other adjustments, net |
( |
( |
( |
|
( |
( |
|||||||
Balance at end of period |
|
|
|
|
|
|
|||||||
of which individually evaluated for impairment |
|
|
|
|
|
|
|||||||
of which collectively evaluated for impairment |
|
|
|
|
|
|
|||||||
1
Measured under the previous accounting guidance (incurred loss model).
|
|||||||||||||
2
Includes a net impact of CHF
|
|||||||||||||
3
Represents the current-period net provision for accrued interest on non-accrual loans
and lease financing transactions which is recognized as a reversal of interest income.
|
6M20 | 6M19 | ||||||||||||
in |
Consumer |
Corporate &
institutional |
Total |
Consumer |
Corporate &
institutional |
Total |
|||||||
Loans held at amortized cost (CHF million) | |||||||||||||
Purchases 1 |
|
|
|
|
|
|
|||||||
Reclassifications from loans held-for-sale 2 |
|
|
|
|
|
|
|||||||
Reclassifications to loans held-for-sale 3 |
|
|
|
|
|
|
|||||||
Sales 3 |
|
|
|
|
|
|
|||||||
1
Includes drawdowns under purchased loan commitments.
|
|||||||||||||
2
Includes loans previously reclassified to held-for-sale that were not sold and were
reclassified back to loans held-to-maturity.
|
|||||||||||||
3
All loans held at amortized cost which are sold are reclassified to loans held-for-sale
on or prior to the date of the sale.
|
6M20 | |||
CHF million | |||
Balance at beginning of period |
|
||
Current-period provision for expected credit losses |
|
||
Gross write-offs |
( |
||
Recoveries |
|
||
Net write-offs |
( |
||
Foreign currency translation impact and other adjustments, net |
( |
||
Balance at end of period |
|
||
of which individually evaluated for impairment |
|
||
of which collectively evaluated for impairment |
|
Investment
grade |
Non-investment
grade |
||||||||
end of | AAA to BBB | BB to C | D | Total | |||||
6M20 (CHF million) | |||||||||
Mortgages | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Loans collateralized by securities | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans 1 |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Consumer finance | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Consumer – total | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
1
Lombard loans are generally classified as revolving loans.
|
Investment
grade |
Non-investment
grade |
||||||||
end of | AAA to BBB | BB to C | D | Total | |||||
6M20 (CHF million) | |||||||||
Real estate | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Commercial and industrial loans | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Financial institutions | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Governments and public institutions | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Corporate & institutional – total | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total |
|
|
|
|
Investment
grade |
Non-investment
grade |
||||||||
end of | AAA to BBB | BB to C | D | Total | |||||
6M20 (CHF million) | |||||||||
Loans held at amortized cost – total | |||||||||
2020 |
|
|
|
|
|||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
2017 |
|
|
|
|
|||||
2016 |
|
|
|
|
|||||
Prior years |
|
|
|
|
|||||
Total term loans |
|
|
|
|
|||||
Revolving loans |
|
|
|
|
|||||
Total loans to third parties |
|
|
|
|
|||||
Total loans to entities under common control |
|
|
|
|
|||||
Total |
|
|
|
|
1 | ||||
Value of collateral 2 |
|
|
|
|
|||||
1
Excludes accrued interest on loans held at amortized cost of CHF
|
|||||||||
2
Includes the value of collateral up to the amount of the outstanding related loans.
For mortgages, the value of collateral is determined at the time of granting the loan
and thereafter regularly reviewed according to the Group's risk management policies
and directives, with maximum review periods determined by property type, market liquidity
and market transparency.
|
Investment
grade |
Non-investment
grade |
||||||||
end of | AAA to BBB | BB to C | D | Total | |||||
2019 (CHF million) | |||||||||
Mortgages 1 |
|
|
|
|
|||||
Loans collateralized by securities 1 |
|
|
|
|
|||||
Consumer finance |
|
|
|
|
|||||
Consumer |
|
|
|
|
|||||
Real estate |
|
|
|
|
|||||
Commercial and industrial loans 1 |
|
|
|
|
|||||
Financial institutions |
|
|
|
|
|||||
Governments and public institutions |
|
|
|
|
|||||
Corporate & institutional |
|
|
|
|
|||||
Gross loans held at amortized cost |
|
|
|
|
|||||
Value of collateral 2 |
|
|
|
|
|||||
1
Certain corporate & institutional loans have been reclassified to consumer loans following
the application of a look-through approach with regard to beneficial owners. Prior
periods have been reclassified to conform to the current presentation.
|
|||||||||
2
Includes the value of collateral up to the amount of the outstanding related loans.
For mortgages, the value of collateral is determined at the time of granting the loan
and thereafter regularly reviewed according to the Group's risk management policies
and directives, with maximum review periods determined by property type, market liquidity
and market transparency.
|
Investment
grade |
Non-investment
grade |
||||||||
end of | AAA to BBB | BB to C | D | Total | |||||
6M20 (CHF million) | |||||||||
Other financial assets held at amortized cost | |||||||||
2019 |
|
|
|
|
|||||
2018 |
|
|
|
|
|||||
Total term positions |
|
|
|
|
|||||
Revolving positions |
|
|
|
|
|||||
Total |
|
|
|
|
|||||
Includes primarily mortgage servicing advances and failed purchases.
|
Current | Past due | ||||||||||||||
end of |
|
Up to
30 days |
31–60
days |
61–90
days |
More than
90 days |
Total |
Total |
||||||||
6M20 (CHF million) | |||||||||||||||
Mortgages |
|
|
|
|
|
|
|
||||||||
Loans collateralized by securities |
|
|
|
|
|
|
|
||||||||
Consumer finance |
|
|
|
|
|
|
|
||||||||
Consumer |
|
|
|
|
|
|
|
||||||||
Real estate |
|
|
|
|
|
|
|
||||||||
Commercial and industrial loans |
|
|
|
|
|
|
|
||||||||
Financial institutions |
|
|
|
|
|
|
|
||||||||
Governments and public institutions |
|
|
|
|
|
|
|
||||||||
Corporate & institutional |
|
|
|
|
|
|
|
||||||||
Total loans to third parties |
|
|
|
|
|
|
|
||||||||
Total loans to entities under common control |
|
|
|
|
|
|
|
||||||||
Total loans held at amortized cost |
|
|
|
|
|
|
|
1 | |||||||
2019 (CHF million) | |||||||||||||||
Mortgages 2 |
|
|
|
|
|
|
|
||||||||
Loans collateralized by securities 2 |
|
|
|
|
|
|
|
||||||||
Consumer finance |
|
|
|
|
|
|
|
||||||||
Consumer |
|
|
|
|
|
|
|
||||||||
Real estate |
|
|
|
|
|
|
|
||||||||
Commercial and industrial loans 2 |
|
|
|
|
|
|
|
||||||||
Financial institutions |
|
|
|
|
|
|
|
||||||||
Governments and public institutions |
|
|
|
|
|
|
|
||||||||
Corporate & institutional |
|
|
|
|
|
|
|
||||||||
Total loans held at amortized cost |
|
|
|
|
|
|
|
||||||||
1
Excludes accrued interest on loans held at amortized cost of CHF 453 million.
|
|||||||||||||||
2
Certain corporate & institutional loans have been reclassified to consumer loans following
the application of a look-through approach with regard to beneficial owners. Prior
periods have been reclassified to conform to the current presentation.
|
6M20 | |||||||||
Amortized cost of non-accrual assets at beginning of period |
Amortized cost of non-accrual assets at end of period |
Interest income recognized |
Amortized
cost of non-accrual assets with no specific allowance at end of period |
||||||
CHF million | |||||||||
Mortgages |
|
|
|
|
|||||
Loans collateralized by securities |
|
|
|
|
|||||
Consumer finance |
|
|
|
|
|||||
Consumer |
|
|
|
|
|||||
Real estate |
|
|
|
|
|||||
Commercial and industrial loans |
|
|
|
|
|||||
Financial institutions |
|
|
|
|
|||||
Corporate & institutional |
|
|
|
|
|||||
Total loans held at amortized cost |
|
|
|
|
6M20 | 6M19 | ||||||||||||
in |
Number of contracts |
Recorded
investment – pre- modification |
Recorded
investment – post- modification |
Number of contracts |
Recorded
investment – pre- modification |
Recorded
investment – post- modification |
|||||||
CHF million, except where indicated | |||||||||||||
Mortgages |
|
|
|
|
|
|
|||||||
Loans collateralized by securities |
|
|
|
|
|
|
|||||||
Commercial and industrial loans |
|
|
|
|
|
|
|||||||
Total loans |
|
|
|
|
|
|
6M20 | 6M19 | ||||||||
in |
Number of
contracts |
Recorded
investment |
Number of
contracts |
Recorded
investment |
|||||
CHF million, except where indicated | |||||||||
Mortgages |
|
|
|
|
|||||
Commercial and industrial loans |
|
|
|
|
|||||
Total loans |
|
|
|
|
6M20 |
Swiss Universal Bank |
International Wealth Management |
Asia Pacific |
Global Markets |
Investment
Banking & Capital Markets |
Bank |
1 | ||||||
Gross amount of goodwill (CHF million) | |||||||||||||
Balance at beginning of period |
|
|
|
|
|
|
|||||||
Goodwill acquired during the year |
|
|
|
|
|
|
|||||||
Foreign currency translation impact |
( |
( |
( |
( |
( |
( |
|||||||
Other |
( |
( |
( |
|
|
( |
|||||||
Balance at end of period |
|
|
|
|
|
|
|||||||
Accumulated impairment (CHF million) | |||||||||||||
Balance at beginning of period |
|
|
|
|
|
|
|||||||
Balance at end of period |
|
|
|
|
|
|
|||||||
Net book value (CHF million) | |||||||||||||
Net book value |
|
|
|
|
|
|
|||||||
1
Gross amount of goodwill and accumulated impairment include goodwill of CHF
|
end of | 6M20 | 2019 | |||
Other assets (CHF million) | |||||
Cash collateral on derivative instruments |
|
|
|||
Cash collateral on non-derivative transactions |
|
|
|||
Derivative instruments used for hedging |
|
|
|||
Assets held-for-sale |
|
|
|||
of which loans 1 |
|
|
|||
allowance for loans held-for-sale |
( |
|
|||
of which real estate 2 |
|
|
|||
of which long-lived assets |
|
|
|||
Premises, equipment and right-of-use assets |
|
|
|||
Assets held for separate accounts |
|
|
|||
Interest and fees receivable |
|
|
|||
Deferred tax assets |
|
|
|||
Prepaid expenses |
|
|
|||
of which cloud computing arrangement implementation costs |
|
|
|||
Failed purchases |
|
|
|||
Defined benefit pension and post-retirement plan assets |
|
|
|||
Other |
|
|
|||
Other assets |
|
|
|||
Other liabilities (CHF million) | |||||
Cash collateral on derivative instruments |
|
|
|||
Cash collateral on non-derivative transactions |
|
|
|||
Derivative instruments used for hedging |
|
|
|||
Operating leases liabilities |
|
|
|||
Provisions |
|
|
|||
of which expected credit losses on off-balance sheet credit exposures |
|
|
|||
Liabilities held for separate accounts |
|
|
|||
Interest and fees payable |
|
|
|||
Current tax liabilities |
|
|
|||
Deferred tax liabilities |
|
|
|||
Failed sales |
|
|
|||
Defined benefit pension and post-retirement plan liabilities |
|
|
|||
Other |
|
|
|||
Other liabilities |
|
|
|||
1
Included as of the end of 6M20 and 2019 were CHF
|
|||||
2
As of the end of 6M20 and 2019, real estate held-for-sale included foreclosed or repossessed
real estate of CHF
|
end of | 6M20 | 2019 | |||
Long-term debt (CHF million) | |||||
Senior |
|
|
|||
Subordinated |
|
|
|||
Non-recourse liabilities from consolidated VIEs |
|
|
|||
Long-term debt |
|
|
|||
of which reported at fair value |
|
|
|||
of which structured notes |
|
|
end of | 6M20 | 2019 | |||
Structured notes by product (CHF million) | |||||
Equity |
|
|
|||
Fixed income |
|
|
|||
Credit |
|
|
|||
Other |
|
|
|||
Total structured notes |
|
|
Gains/ (losses) on cash flow hedges |
Cumulative translation adjustments |
Unrealized
gains/ (losses) on securities |
1 |
Actuarial gains/ (losses) |
Net prior service credit/ (cost) |
Gains/
(losses) on liabilities relating to credit risk |
AOCI |
||||||||
6M20 (CHF million) | |||||||||||||||
Balance at beginning of period |
|
( |
|
( |
( |
( |
( |
||||||||
Increase/(decrease) |
|
( |
( |
|
|
|
|
||||||||
Reclassification adjustments, included in net income/(loss) |
|
|
|
|
|
|
|
||||||||
Total increase/(decrease) |
|
( |
( |
|
|
|
|
||||||||
Balance at end of period |
|
( |
|
( |
( |
( |
( |
||||||||
6M19 (CHF million) | |||||||||||||||
Balance at beginning of period |
( |
( |
|
( |
( |
( |
( |
||||||||
Increase/(decrease) |
|
( |
|
|
|
( |
( |
||||||||
Reclassification adjustments, included in net income/(loss) |
|
|
|
|
|
|
|
||||||||
Cumulative effect of accounting changes, net of tax |
|
|
|
( |
|
( |
( |
||||||||
Total increase/(decrease) |
|
( |
|
( |
|
( |
( |
||||||||
Balance at end of period |
|
( |
|
( |
( |
( |
( |
||||||||
1
No impairments on available-for-sale debt securities were recognized in net income/(loss)
in 6M20 and 6M19.
|
in | 6M20 | 6M19 | |||
Reclassification adjustments, included in net income/(loss) (CHF million) | |||||
Cumulative translation adjustments | |||||
Reclassification adjustments |
|
|
|||
Actuarial gains/(losses) | |||||
Amortization of recognized actuarial losses 1 |
|
|
|||
Tax expense/(benefit) |
|
( |
|||
Net of tax |
|
|
|||
1
These components are included in the computation of total benefit costs. Refer to
"Note 25 – Pension and other post-retirement benefits" for further information.
|
6M20 | 2019 | ||||||||
end of |
Derivative
assets |
Derivative
liabilities |
Derivative
assets |
Derivative
liabilities |
|||||
Gross derivatives subject to enforceable master netting agreements (CHF billion) | |||||||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Interest rate products |
|
|
|
|
|||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Foreign exchange products |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Equity/index-related products |
|
|
|
|
|||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Credit derivatives |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Other products 1 |
|
|
|
|
|||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Total gross derivatives subject to enforceable master netting agreements |
|
|
|
|
|||||
Offsetting (CHF billion) | |||||||||
OTC-cleared |
( |
( |
( |
( |
|||||
OTC |
( |
( |
( |
( |
|||||
Exchange-traded |
( |
( |
( |
( |
|||||
Offsetting |
( |
( |
( |
( |
|||||
of which counterparty netting |
( |
( |
( |
( |
|||||
of which cash collateral netting |
( |
( |
( |
( |
|||||
Net derivatives presented in the consolidated balance sheets (CHF billion) | |||||||||
OTC-cleared |
|
|
|
|
|||||
OTC |
|
|
|
|
|||||
Exchange-traded |
|
|
|
|
|||||
Total net derivatives subject to enforceable master netting agreements |
|
|
|
|
|||||
Total derivatives not subject to enforceable master netting agreements 2 |
|
|
|
|
|||||
Total net derivatives presented in the consolidated balance sheets |
|
|
|
|
|||||
of which recorded in trading assets and trading liabilities |
|
|
|
|
|||||
of which recorded in other assets and other liabilities |
|
|
|
|
|||||
1
Primarily precious metals, commodity and energy products.
|
|||||||||
2
Represents derivatives where a legal opinion supporting the enforceability of netting
in the event of default or termination under the agreement is not in place.
|
6M20 | 2019 | ||||||||||||
end of |
Gross |
Offsetting |
Net
book value |
Gross |
Offsetting |
Net
book value |
|||||||
Securities purchased under resale agreements and securities borrowing transactions (CHF billion) | |||||||||||||
Securities purchased under resale agreements |
|
( |
|
|
( |
|
|||||||
Securities borrowing transactions |
|
( |
|
|
( |
|
|||||||
Total subject to enforceable master netting agreements |
|
( |
|
|
( |
|
|||||||
Total not subject to enforceable master netting agreements 1 |
|
– |
|
|
– |
|
|||||||
Total |
|
( |
|
2 |
|
( |
|
2 | |||||
1
Represents securities purchased under resale agreements and securities borrowing transactions
where a legal opinion supporting the enforceability of netting in the event of default
or termination under the agreement is not in place.
|
|||||||||||||
2
CHF
|
6M20 | 2019 | ||||||||||||
end of |
Gross |
Offsetting |
Net
book value |
Gross |
Offsetting |
Net
book value |
|||||||
Securities sold under repurchase agreements and securities lending transactions (CHF billion) | |||||||||||||
Securities sold under repurchase agreements |
|
( |
|
|
( |
|
|||||||
Securities lending transactions |
|
|
|
|
|
|
|||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
|
|||||||
Total subject to enforceable master netting agreements |
|
( |
|
|
( |
|
|||||||
Total not subject to enforceable master netting agreements 1 |
|
– |
|
|
– |
|
|||||||
Total |
|
( |
|
|
( |
|
|||||||
of which securities sold under repurchase agreements and securities lending transactions |
|
( |
|
2 |
|
( |
|
2 | |||||
of which obligation to return securities received as collateral, at fair value |
|
|
|
|
|
|
|||||||
1
Represents securities sold under repurchase agreements and securities lending transactions
where a legal opinion supporting the enforceability of netting in the event of default
or termination under the agreement is not in place.
|
|||||||||||||
2
CHF
|
6M20 | 2019 | ||||||||||||||||
end of |
Net |
Financial instruments |
1 |
Cash
collateral received/ pledged |
1 |
Net exposure |
Net |
Financial instruments |
1 |
Cash
collateral received/ pledged |
1 |
Net exposure |
|||||
Financial assets subject to enforceable master netting agreements (CHF billion) | |||||||||||||||||
Derivatives |
|
|
|
|
|
|
|
|
|||||||||
Securities purchased under resale agreements |
|
|
|
|
|
|
|
|
|||||||||
Securities borrowing transactions |
|
|
|
|
|
|
|
|
|||||||||
Total financial assets subject to enforceable master netting agreements |
|
|
|
|
|
|
|
|
|||||||||
Financial liabilities subject to enforceable master netting agreements (CHF billion) | |||||||||||||||||
Derivatives |
|
|
|
|
|
|
|
|
|||||||||
Securities sold under repurchase agreements |
|
|
|
|
|
|
|
|
|||||||||
Securities lending transactions |
|
|
|
|
|
|
|
|
|||||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
|
|
|
|||||||||
Total financial liabilities subject to enforceable master netting agreements |
|
|
|
|
|
|
|
|
|||||||||
1
The total amount reported in financial instruments (recognized financial assets and
financial liabilities and non-cash financial collateral) and cash collateral is limited
to the amount of the related instruments presented in the consolidated balance sheets
and therefore any over-collateralization of these positions is not included.
|
in | 6M20 | 6M19 | |||
Effective tax rate (%) |
|
|
in | 6M20 | ||
CHF million | |||
Income tax expense computed at the statutory tax rate of 20% |
|
||
Increase/(decrease) in income taxes resulting from | |||
Foreign tax rate differential |
|
||
Other non-deductible expenses |
|
||
Changes in deferred tax valuation allowance |
( |
||
Lower taxed income |
( |
||
(Windfall tax benefits)/shortfall tax charges on share-based compensation |
|
||
Other |
( |
||
Income tax expense |
|
end of | 6M20 | 2019 | |||
Net deferred tax assets (CHF million) | |||||
Deferred tax assets |
|
|
|||
of which net operating losses |
|
|
|||
of which deductible temporary differences |
|
|
|||
Deferred tax liabilities |
( |
( |
|||
Net deferred tax assets |
|
|
in | 6M20 | 6M19 | |||
Deferred compensation expense (CHF million) | |||||
Share awards |
|
|
1 | ||
Performance share awards |
|
|
|||
Contingent Capital Awards |
|
|
|||
Deferred cash awards |
|
|
1 | ||
Retention awards |
|
|
1 | ||
Total deferred compensation expense |
|
|
|||
1
Prior period has been reclassifed to conform to the current presentation.
|
end of | 6M20 | ||
Estimated unrecognized compensation expense (CHF million) | |||
Share awards |
|
||
Performance share awards |
|
||
Contingent Capital Awards |
|
||
Deferred cash awards |
|
||
Retention awards |
|
||
Total |
|
||
Weighted-average requisite service period (years) | |||
Aggregate remaining weighted-average requisite service period |
|
6M20 | |||||
Number of awards (in millions) |
Share awards |
Performance
share awards |
|||
Share-based award activities | |||||
Balance at beginning of period |
|
|
|||
Granted |
|
|
|||
Settled |
( |
( |
|||
Forfeited |
( |
( |
|||
Balance at end of period |
|
|
|||
of which vested |
|
|
|||
of which unvested |
|
|
in | 6M20 | 6M19 | |||
Net periodic benefit costs/(credits) (CHF million) | |||||
Service costs on benefit obligation |
|
|
|||
Interest costs on benefit obligation |
|
|
|||
Expected return on plan assets |
( |
( |
|||
Amortization of recognized prior service cost/(credit) |
|
|
|||
Amortization of recognized actuarial losses |
|
|
|||
Net periodic benefit costs |
|
|
|||
Service costs on benefit obligation are reflected in compensation and benefits. Other
components of net periodic benefit costs are reflected in general and administrative
expenses.
|
Trading | Hedging | 1 | |||||||||||
end of 6M20 |
Notional amount |
Positive
replacement value (PRV) |
Negative
replacement value (NRV) |
Notional amount |
Positive
replacement value (PRV) |
Negative
replacement value (NRV) |
|||||||
Derivative instruments (CHF billion) | |||||||||||||
Forwards and forward rate agreements |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Interest rate products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Foreign exchange products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Equity/index-related products |
|
|
|
|
|
|
|||||||
Credit derivatives 2 |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Other products 3 |
|
|
|
|
|
|
|||||||
Total derivative instruments |
|
|
|
|
|
|
|||||||
The notional amount, PRV and NRV (trading and hedging) was CHF
|
|||||||||||||
1
Relates to derivative contracts that qualify for hedge accounting under US GAAP.
|
|||||||||||||
2
Primarily credit default swaps.
|
|||||||||||||
3
Primarily precious metals, commodity and energy products.
|
Trading | Hedging | 1 | |||||||||||
end of 2019 |
Notional amount |
Positive
replacement value (PRV) |
Negative
replacement value (NRV) |
Notional amount |
Positive
replacement value (PRV) |
Negative
replacement value (NRV) |
|||||||
Derivative instruments (CHF billion) | |||||||||||||
Forwards and forward rate agreements |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Interest rate products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Foreign exchange products |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Equity/index-related products |
|
|
|
|
|
|
|||||||
Credit derivatives 2 |
|
|
|
|
|
|
|||||||
Forwards |
|
|
|
|
|
|
|||||||
Swaps |
|
|
|
|
|
|
|||||||
Options bought and sold (OTC) |
|
|
|
|
|
|
|||||||
Futures |
|
|
|
|
|
|
|||||||
Options bought and sold (exchange-traded) |
|
|
|
|
|
|
|||||||
Other products 3 |
|
|
|
|
|
|
|||||||
Total derivative instruments |
|
|
|
|
|
|
|||||||
The notional amount, PRV and NRV (trading and hedging) was CHF
|
|||||||||||||
1
Relates to derivative contracts that qualify for hedge accounting under US GAAP.
|
|||||||||||||
2
Primarily credit default swaps.
|
|||||||||||||
3
Primarily precious metals, commodity and energy products.
|
in | 6M20 | 6M19 | |||
Interest rate products (CHF million) | |||||
Hedged items 1 |
( |
( |
|||
Derivatives designated as hedging instruments 1 |
|
|
|||
The accrued interest on fair value hedges is recorded in net interest income and is
excluded from this table.
|
|||||
1
Included in net interest income.
|
6M20 | 2019 | ||||||||||||
Hedged items | Hedged items | ||||||||||||
end of |
Carrying
amount |
Hedging
adjustments |
1 |
Disconti-
nued hedges |
2 |
Carrying
amount |
Hedging
adjustments |
1 |
Disconti-
nued hedges |
2 | |||
Assets and liabilities (CHF billion) | |||||||||||||
Net loans |
|
|
|
|
|
|
|||||||
Long-term debt |
|
|
|
|
|
|
|||||||
1
Relates to the cumulative amount of fair value hedging adjustments included in the
carrying amount.
|
|||||||||||||
2
Relates to the cumulative amount of fair value hedging adjustments remaining for any
hedged items for which hedge accounting has been discontinued.
|
in | 6M20 | 6M19 | |||
Interest rate products (CHF million) | |||||
Gains/(losses) recognized in AOCI on derivatives |
|
|
|||
Gains/(losses) reclassified from AOCI into interest and dividend income |
( |
|
Foreign exchange products (CHF million) | |||||
Gains/(losses) recognized in AOCI on derivatives |
( |
( |
|||
Trading revenues |
( |
|
|||
Total other operating expenses |
( |
( |
|||
Gains/(losses) reclassified from AOCI into income |
( |
( |
|||
Gains/(losses) excluded from the assessment of effectiveness reported in trading revenues 1 |
|
( |
in | 6M20 | 6M19 | |||
Foreign exchange products (CHF million) | |||||
Gains/(losses) recognized in the cumulative translation adjustments section of AOCI |
|
( |
|||
Gains/(losses) reclassified from the cumulative translation adjustments section of AOCI into other revenues |
|
|
6M20 | 2019 | ||||||||||||||||
end of |
Bilateral counterparties |
Special
purpose entities |
Accelerated terminations |
Total |
Bilateral counterparties |
Special
purpose entities |
Accelerated terminations |
Total |
|||||||||
Contingent credit risk (CHF billion) | |||||||||||||||||
Current net exposure |
|
|
|
|
|
|
|
|
|||||||||
Collateral posted |
|
|
– |
|
|
|
– |
|
|||||||||
Impact of a one-notch downgrade event |
|
|
|
|
|
|
|
|
|||||||||
Impact of a two-notch downgrade event |
|
|
|
|
|
|
|
|
|||||||||
Impact of a three-notch downgrade event |
|
|
|
|
|
|
|
|
|||||||||
The impact of a downgrade event reflects the amount of additional collateral required
for bilateral counterparties and special purpose entities and the amount of additional
termination expenses for accelerated terminations, respectively.
|
6M20 | 2019 | ||||||||||||||||||||
end of |
Credit protection sold |
Credit protection purchased |
1 |
Net credit
protection (sold)/ purchased |
Other protection purchased |
Fair value
of credit protection sold |
Credit protection sold |
Credit protection purchased |
1 |
Net credit
protection (sold)/ purchased |
Other protection purchased |
Fair value
of credit protection sold |
|||||||||
Single-name instruments (CHF billion) | |||||||||||||||||||||
Investment grade 2 |
( |
|
( |
|
|
( |
|
( |
|
|
|||||||||||
Non-investment grade |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Total single-name instruments |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which non-sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Multi-name instruments (CHF billion) | |||||||||||||||||||||
Investment grade 2 |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Non-investment grade |
( |
|
( |
|
3 |
( |
( |
|
( |
|
3 |
|
|||||||||
Total multi-name instruments |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which non-sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Total instruments (CHF billion) | |||||||||||||||||||||
Investment grade 2 |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Non-investment grade |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
Total instruments |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
of which non-sovereign |
( |
|
( |
|
( |
( |
|
( |
|
|
|||||||||||
1
Represents credit protection purchased with identical underlyings and recoveries.
|
|||||||||||||||||||||
2
Based on internal ratings of BBB and above.
|
|||||||||||||||||||||
3
Includes synthetic securitized loan portfolios.
|
end of | 6M20 | 2019 | |||
Credit derivatives (CHF billion) | |||||
Credit protection sold |
|
|
|||
Credit protection purchased |
|
|
|||
Other protection purchased |
|
|
|||
Other instruments 1 |
|
|
|||
Total credit derivatives |
|
|
|||
1
Consists of total return swaps and other derivative instruments.
|
end of |
Maturity
less than 1 year |
Maturity
between 1 to 5 years |
Maturity
greater than 5 years |
Total |
|||||
6M20 (CHF billion) | |||||||||
Single-name instruments |
|
|
|
|
|||||
Multi-name instruments |
|
|
|
|
|||||
Total instruments |
|
|
|
|
|||||
2019 (CHF billion) | |||||||||
Single-name instruments |
|
|
|
|
|||||
Multi-name instruments |
|
|
|
|
|||||
Total instruments |
|
|
|
|
end of |
Maturity
less than 1 year |
Maturity
greater than 1 year |
Total gross amount |
Total net amount |
1 |
Carrying value |
Collateral received |
||||||
6M20 (CHF million) | |||||||||||||
Credit guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Performance guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Securities lending indemnifications |
|
|
|
|
|
|
|||||||
Derivatives 2 |
|
|
|
|
|
– | 3 | ||||||
Other guarantees |
|
|
|
|
|
|
|||||||
Total guarantees |
|
|
|
|
|
|
|||||||
2019 (CHF million) | |||||||||||||
Credit guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Performance guarantees and similar instruments |
|
|
|
|
|
|
|||||||
Derivatives 2 |
|
|
|
|
|
– | 3 | ||||||
Other guarantees |
|
|
|
|
|
|
|||||||
Total guarantees |
|
|
|
|
|
|
|||||||
1
Total net amount is computed as the gross amount less any participations.
|
|||||||||||||
2
Excludes derivative contracts with certain active commercial and investment banks
and certain other counterparties, as such contracts can be cash settled and the Bank
had no basis to conclude it was probable that the counterparties held, at inception,
the underlying instruments.
|
|||||||||||||
3
Collateral for derivatives accounted for as guarantees is not considered significant.
|
6M20 | 2019 | ||||||||||||||||||||
end of |
Maturity
less than 1 year |
Maturity
greater than 1 year |
Total gross amount |
Total net amount |
1 |
Collateral received |
Maturity
less than 1 year |
Maturity
greater than 1 year |
Total gross amount |
Total net amount |
1 |
Collateral received |
|||||||||
Other commitments (CHF million) | |||||||||||||||||||||
Irrevocable commitments under documentary credits |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Irrevocable loan commitments |
|
|
|
2 |
|
|
|
|
|
2 |
|
|
|||||||||
Forward reverse repurchase agreements |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other commitments |
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total other commitments |
|
|
|
|
|
|
|
|
|
|
|||||||||||
1
Total net amount is computed as the gross amount less any participations.
|
|||||||||||||||||||||
2
Irrevocable loan commitments do not include a total gross amount of CHF
|
in | 6M20 | 6M19 | |||
Gains/(losses) and cash flows (CHF million) | |||||
CMBS | |||||
Net gain/(loss) 1 |
|
( |
|||
Proceeds from transfer of assets |
|
|
|||
Cash received on interests that continue to be held |
|
|
|||
RMBS | |||||
Net gain/(loss) 1 |
|
( |
|||
Proceeds from transfer of assets |
|
|
|||
Purchases of previously transferred financial assets or its underlying collateral |
|
( |
|||
Servicing fees |
|
|
|||
Cash received on interests that continue to be held |
|
|
|||
Other asset-backed financings | |||||
Net gain 1 |
|
|
|||
Proceeds from transfer of assets |
|
|
|||
Purchases of previously transferred financial assets or its underlying collateral |
( |
( |
|||
Fees 2 |
|
|
|||
Cash received on interests that continue to be held |
|
|
|||
1
Includes underwriting revenues, deferred origination fees, gains or losses on the
sale of collateral to the SPE and gains or losses on the sale of newly issued securities
to third parties, but excludes net interest income on assets prior to the securitization.
The gains or losses on the sale of the collateral is the difference between the fair
value on the day prior to the securitization pricing date and the sale price of the
loans.
|
|||||
2
Represents management fees and performance fees earned for investment management services
provided to managed CLOs.
|
end of | 6M20 | 2019 | |||
CHF million | |||||
CMBS | |||||
Principal amount outstanding |
|
|
|||
Total assets of SPE |
|
|
|||
RMBS | |||||
Principal amount outstanding |
|
|
|||
Total assets of SPE |
|
|
|||
Other asset-backed financings | |||||
Principal amount outstanding |
|
|
|||
Total assets of SPE |
|
|
|||
Principal amount outstanding relates to assets transferred from the Bank and does
not include principle amounts for assets transferred from third parties.
|
6M20 | 6M19 | ||||||||||||||||
at time of transfer, in | CMBS | RMBS | CMBS | RMBS | |||||||||||||
CHF million, except where indicated | |||||||||||||||||
Fair value of beneficial interests |
|
|
|
|
|||||||||||||
of which level 2 |
|
|
|
|
|||||||||||||
of which level 3 |
|
|
|
|
|||||||||||||
Weighted-average life, in years |
|
|
|
|
|||||||||||||
Prepayment speed assumption (rate per annum), in % 1 | – | 2 |
|
– |
|
– | 2 |
|
– |
|
|||||||
Cash flow discount rate (rate per annum), in % 3 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||
Expected credit losses (rate per annum), in % 4 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||
Transfers of assets in which the Bank does not have beneficial interests are not included
in this table.
|
|||||||||||||||||
1
Prepayment speed assumption (PSA) is an industry standard prepayment speed metric
used for projecting prepayments over the life of a residential mortgage loan. PSA
utilizes the constant prepayment rate (CPR) assumptions. A
|
|||||||||||||||||
2
To deter prepayment, commercial mortgage loans typically have prepayment protection
in the form of prepayment lockouts and yield maintenances.
|
|||||||||||||||||
3
The rate was based on the weighted-average yield on the beneficial interests.
|
|||||||||||||||||
4
The range of expected credit losses only reflects instruments with an expected credit
loss greater than zero unless all of the instruments have an expected credit loss
of zero.
|
6M20 | 2019 | ||||||||||||||||||||||||
end of |
CMBS |
1 |
RMBS |
Other asset-
backed financing activities |
2 |
CMBS |
1 |
RMBS |
Other asset-
backed financing activities |
2 | |||||||||||||||
CHF million, except where indicated | |||||||||||||||||||||||||
Fair value of beneficial interests |
|
|
|
|
|
|
|||||||||||||||||||
of which non-investment grade |
|
|
|
|
|
|
|||||||||||||||||||
Weighted-average life, in years |
|
|
|
|
|
|
|||||||||||||||||||
Prepayment speed assumption (rate per annum), in % 3 | – |
|
– |
|
– | – |
|
– |
|
– | |||||||||||||||
Impact on fair value from 10% adverse change | – |
( |
– | – |
( |
– | |||||||||||||||||||
Impact on fair value from 20% adverse change | – |
( |
– | – |
( |
– | |||||||||||||||||||
Cash flow discount rate (rate per annum), in % 4 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||||
Impact on fair value from 10% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
Impact on fair value from 20% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
Expected credit losses (rate per annum), in % 5 |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|||||||
Impact on fair value from 10% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
Impact on fair value from 20% adverse change |
( |
( |
( |
( |
( |
( |
|||||||||||||||||||
1
To deter prepayment, commercial mortgage loans typically have prepayment protection
in the form of prepayment lockouts and yield maintenances.
|
|||||||||||||||||||||||||
2
CDOs within this category are generally structured to be protected from prepayment
risk.
|
|||||||||||||||||||||||||
3
PSA is an industry standard prepayment speed metric used for projecting prepayments
over the life of a residential mortgage loan. PSA utilizes the CPR assumptions. A
|
|||||||||||||||||||||||||
4
The rate was based on the weighted-average yield on the beneficial interests.
|
|||||||||||||||||||||||||
5
The range of expected credit losses only reflects instruments with an expected credit
loss greater than zero unless all of the instruments have an expected credit loss
of zero.
|
end of | 6M20 | 2019 | |||
CHF million | |||||
Other asset-backed financings | |||||
Trading assets |
|
|
|||
Other assets |
|
|
|||
Liability to SPE, included in other liabilities |
( |
( |
end of | 6M20 | 2019 | |||
CHF billion | |||||
Government debt securities 1 |
|
|
|||
Corporate debt securities 1 |
|
|
|||
Asset-backed securities |
|
|
|||
Equity securities |
|
|
|||
Other |
|
|
|||
Securities sold under repurchase agreements |
|
|
|||
Government debt securities |
|
|
|||
Corporate debt securities |
|
|
|||
Equity securities |
|
|
|||
Other |
|
|
|||
Securities lending transactions |
|
|
|||
Government debt securities |
|
|
|||
Corporate debt securities |
|
|
|||
Asset-backed securities |
|
|
|||
Equity securities |
|
|
|||
Obligation to return securities received as collateral, at fair value |
|
|
|||
Total |
|
|
|||
1
Prior period has been corrected.
|
Remaining contractual maturities | |||||||||||
end of |
On demand |
1 |
Up to
30 days |
2 |
31-90
days |
More than
90 days |
Total |
||||
6M20 (CHF billion) | |||||||||||
Securities sold under repurchase agreements |
|
|
|
|
|
||||||
Securities lending transactions |
|
|
|
|
|
||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
||||||
Total |
|
|
|
|
|
||||||
2019 (CHF billion) | |||||||||||
Securities sold under repurchase agreements |
|
|
|
|
|
||||||
Securities lending transactions |
|
|
|
|
|
||||||
Obligation to return securities received as collateral, at fair value |
|
|
|
|
|
||||||
Total |
|
|
|
|
|
||||||
1
Includes contracts with no contractual maturity that may contain termination arrangements
subject to a notice period.
|
|||||||||||
2
Includes overnight transactions.
|
Financial intermediation | |||||||||||||||
end of |
CDO/
CLO |
CP
Conduit |
Securi-
tizations |
Funds |
Loans |
Other |
Total |
||||||||
6M20 (CHF million) | |||||||||||||||
Cash and due from banks |
|
|
|
|
|
|
|
||||||||
Trading assets |
|
|
|
|
|
|
|
||||||||
Other investments |
|
|
|
|
|
|
|
||||||||
Net loans |
|
|
|
|
|
|
|
||||||||
Other assets |
|
|
|
|
|
|
|
||||||||
of which loans held-for-sale |
|
|
|
|
|
|
|
||||||||
of which premises and equipment |
|
|
|
|
|
|
|
||||||||
Total assets of consolidated VIEs |
|
|
|
|
|
|
|
||||||||
Trading liabilities |
|
|
|
|
|
|
|
||||||||
Short-term borrowings |
|
|
|
|
|
|
|
||||||||
Long-term debt |
|
|
|
|
|
|
|
||||||||
Other liabilities |
|
|
|
|
|
|
|
||||||||
Total liabilities of consolidated VIEs |
|
|
|
|
|
|
|
||||||||
2019 (CHF million) | |||||||||||||||
Cash and due from banks |
|
|
|
|
|
|
|
||||||||
Trading assets |
|
|
|
|
|
|
|
||||||||
Other investments |
|
|
|
|
|
|
|
||||||||
Net loans |
|
|
|
|
|
|
|
||||||||
Other assets |
|
|
|
|
|
|
|
||||||||
of which loans held-for-sale |
|
|
|
|
|
|
|
||||||||
of which premises and equipment |
|
|
|
|
|
|
|
||||||||
Total assets of consolidated VIEs |
|
|
|
|
|
|
|
||||||||
Trading liabilities |
|
|
|
|
|
|
|
||||||||
Short-term borrowings |
|
|
|
|
|
|
|
||||||||
Long-term debt |
|
|
|
|
|
|
|
||||||||
Other liabilities |
|
|
|
|
|
|
|
||||||||
Total liabilities of consolidated VIEs |
|
|
|
|
|
|
|
Financial intermediation | |||||||||||||
end of |
CDO/
CLO |
Securi-
tizations |
Funds |
Loans |
Other |
Total |
|||||||
6M20 (CHF million) | |||||||||||||
Trading assets |
|
|
|
|
|
|
|||||||
Net loans |
|
|
|
|
|
|
|||||||
Other assets |
|
|
|
|
|
|
|||||||
Total variable interest assets |
|
|
|
|
|
|
|||||||
Maximum exposure to loss |
|
|
|
|
|
|
|||||||
Total assets of non-consolidated VIEs |
|
|
|
|
|
|
|||||||
2019 (CHF million) | |||||||||||||
Trading assets |
|
|
|
|
|
|
|||||||
Net loans |
|
|
|
|
|
|
|||||||
Other assets |
|
|
|
|
|
|
|||||||
Total variable interest assets |
|
|
|
|
|
|
|||||||
Maximum exposure to loss |
|
|
|
|
|
|
|||||||
Total assets of non-consolidated VIEs |
|
|
|
|
|
|
end of 6M20 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Assets
measured at net asset value per share |
2 |
Total |
|||||
Assets (CHF million) | |||||||||||||
Cash and due from banks |
|
|
|
– | – |
|
|||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
– | – |
|
|||||||
Securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading assets |
|
|
|
( |
|
|
|||||||
of which debt securities |
|
|
|
– | – |
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which corporates |
|
|
|
– | – |
|
|||||||
of which RMBS |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
of which credit derivatives |
|
|
|
– | – | – | |||||||
of which other derivatives |
|
|
|
– | – | – | |||||||
of which other trading assets |
|
|
|
– | – |
|
|||||||
Investment securities |
|
|
|
– | – |
|
|||||||
Other investments |
|
|
|
– |
|
|
|||||||
of which other equity investments |
|
|
|
– |
|
|
|||||||
of which life finance instruments |
|
|
|
– | – |
|
|||||||
Loans |
|
|
|
– | – |
|
|||||||
of which commercial and industrial loans |
|
|
|
– | – |
|
|||||||
of which financial institutions |
|
|
|
– | – |
|
|||||||
of which government and public institutions |
|
|
|
– | – |
|
|||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
– | – |
|
|||||||
Other assets |
|
|
|
( |
– |
|
|||||||
of which loans held-for-sale |
|
|
|
– | – |
|
|||||||
Total assets at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting
represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using
the net asset value per share practical expedient have not been classified in the
fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
end of 6M20 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Liabilities
measured at net asset value per share |
2 |
Total |
|||||
Liabilities (CHF million) | |||||||||||||
Due to banks |
|
|
|
– | – |
|
|||||||
Customer deposits |
|
|
|
– | – |
|
|||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
– | – |
|
|||||||
Obligation to return securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading liabilities |
|
|
|
( |
|
|
|||||||
of which debt securities |
|
|
|
– | – |
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
of which credit derivatives |
|
|
|
– | – | – | |||||||
Short-term borrowings |
|
|
|
– | – |
|
|||||||
Long-term debt |
|
|
|
– | – |
|
|||||||
of which structured notes over one year and up to two years |
|
|
|
– | – |
|
|||||||
of which structured notes over two years |
|
|
|
– | – |
|
|||||||
of which high-trigger instruments |
|
|
|
– | – |
|
|||||||
of which other subordinated bonds |
|
|
|
– | – |
|
|||||||
of which non-recourse liabilities |
|
|
|
– | – |
|
|||||||
Other liabilities |
|
|
|
( |
– |
|
|||||||
Total liabilities at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting
represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using
the net asset value per share practical expedient have not been classified in the
fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
end of 2019 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Assets
measured at net asset value per share |
2 |
Total |
|||||
Assets (CHF million) | |||||||||||||
Cash and due from banks |
|
|
|
– | – |
|
|||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
– | – |
|
|||||||
Securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading assets |
|
|
|
( |
|
|
|||||||
of which debt securities |
|
|
|
– | – |
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which corporates |
|
|
|
– | – |
|
|||||||
of which RMBS |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
of which credit derivatives |
|
|
|
– | – | – | |||||||
of which other derivatives |
|
|
|
– | – | – | |||||||
of which other trading assets |
|
|
|
– | – |
|
|||||||
Investment securities |
|
|
|
– | – |
|
|||||||
Other investments |
|
|
|
– |
|
|
|||||||
of which other equity investments |
|
|
|
– |
|
|
|||||||
of which life finance instruments |
|
|
|
– | – |
|
|||||||
Loans |
|
|
|
– | – |
|
|||||||
of which commercial and industrial loans |
|
|
|
– | – |
|
|||||||
of which financial institutions |
|
|
|
– | – |
|
|||||||
of which government and public institutions |
|
|
|
|
|||||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
– | – |
|
|||||||
Other assets |
|
|
|
( |
– |
|
|||||||
of which loans held-for-sale |
|
|
|
– | – |
|
|||||||
Total assets at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting
represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using
the net asset value per share practical expedient have not been classified in the
fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
end of 2019 |
Level 1 |
Level 2 |
Level 3 |
Netting impact |
1 |
Liabilities
measured at net asset value per share |
2 |
Total |
|||||
Liabilities (CHF million) | |||||||||||||
Due to banks |
|
|
|
– | – |
|
|||||||
Customer deposits |
|
|
|
– | – |
|
|||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
– | – |
|
|||||||
Obligation to return securities received as collateral |
|
|
|
– | – |
|
|||||||
Trading liabilities |
|
|
|
( |
|
|
|||||||
of which debt securities |
|
|
|
– | – |
|
|||||||
of which foreign government |
|
|
|
– | – |
|
|||||||
of which equity securities |
|
|
|
– |
|
|
|||||||
of which derivatives |
|
|
|
( |
– |
|
|||||||
of which interest rate products |
|
|
|
– | – | – | |||||||
of which foreign exchange products |
|
|
|
– | – | – | |||||||
of which equity/index-related products |
|
|
|
– | – | – | |||||||
of which credit derivatives |
|
|
|
– | – | – | |||||||
Short-term borrowings |
|
|
|
– | – |
|
|||||||
Long-term debt |
|
|
|
– | – |
|
|||||||
of which structured notes over one year and up to two years |
|
|
|
– | – |
|
|||||||
of which structured notes over two years |
|
|
|
– | – |
|
|||||||
of which high-trigger instruments |
|
|
|
|
|||||||||
of which other subordinated bonds |
|
|
|
– | – |
|
|||||||
Other liabilities |
|
|
|
( |
– |
|
|||||||
Total liabilities at fair value |
|
|
|
( |
|
|
|||||||
1
Derivative contracts are reported on a gross basis by level. The impact of netting
represents legally enforceable master netting agreements.
|
|||||||||||||
2
In accordance with US GAAP, certain investments that are measured at fair value using
the net asset value per share practical expedient have not been classified in the
fair value
hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the consolidated balance sheet. |
Trading revenues |
Other revenues |
Accumulated other
comprehensive income |
|||||||||||||||||||||||||||||||
6M20 |
Balance at beginning of period |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
Settlements |
On transfers out |
On all other |
On transfers out |
On all other |
On transfers out |
On all other |
Foreign
currency translation impact |
Balance at end of period |
Changes in unrealized gains/losses |
1 | ||||||||||||||||
Assets (CHF million) | |||||||||||||||||||||||||||||||||
Securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Trading assets |
|
|
( |
|
( |
|
( |
|
|
( |
|
|
|
( |
|
|
|||||||||||||||||
of which debt securities |
|
|
( |
|
( |
|
|
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which foreign governments |
|
|
( |
|
( |
|
|
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which corporates |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which RMBS |
|
|
( |
|
( |
|
|
( |
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which equity securities |
|
|
( |
|
( |
|
|
|
( |
|
|
|
|
( |
|
|
|||||||||||||||||
of which derivatives |
|
|
( |
|
|
|
( |
|
|
( |
|
|
|
( |
|
|
|||||||||||||||||
of which interest rate products |
|
|
( |
|
|
|
( |
( |
|
( |
|
|
|
( |
|
|
|||||||||||||||||
of which foreign exchange derivatives |
|
|
( |
|
|
|
( |
( |
|
|
|
|
|
( |
|
( |
|||||||||||||||||
of which equity/index-related products |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which credit derivatives |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which other derivatives |
|
|
|
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which other trading assets |
|
|
( |
|
( |
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
Other investments |
|
|
|
|
( |
|
|
|
|
|
( |
|
|
( |
|
|
|||||||||||||||||
of which other equity investments |
|
|
|
|
( |
|
|
|
( |
|
( |
|
|
( |
|
( |
|||||||||||||||||
of which life finance instruments |
|
|
|
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Loans 2 |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which commercial and industrial loans 2 |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which financial institutions |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which government and public institutions |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
|
|
|
|
|
|
|
( |
|
|
( |
|
( |
|||||||||||||||||
Other assets |
|
|
( |
|
( |
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which loans held-for-sale |
|
|
( |
|
( |
|
( |
( |
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
Total assets at fair value |
|
|
( |
|
( |
|
( |
|
|
( |
( |
|
|
( |
|
|
|||||||||||||||||
Liabilities (CHF million) | |||||||||||||||||||||||||||||||||
Customer deposits |
|
|
|
|
|
|
( |
|
|
|
|
|
( |
( |
|
|
|||||||||||||||||
Obligation to return securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Trading liabilities |
|
|
( |
|
( |
|
( |
|
( |
( |
|
|
|
( |
|
|
|||||||||||||||||
of which equity securities |
|
|
|
|
( |
|
|
|
( |
|
|
|
|
( |
|
|
|||||||||||||||||
of which derivatives |
|
|
( |
|
( |
|
( |
|
( |
( |
|
|
|
( |
|
|
|||||||||||||||||
of which interest rate derivatives |
|
|
( |
|
|
|
( |
( |
|
( |
|
|
|
( |
|
|
|||||||||||||||||
of which foreign exchange derivatives |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which equity/index-related derivatives |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
( |
|
|
|||||||||||||||||
of which credit derivatives |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
( |
|
|
|||||||||||||||||
Short-term borrowings |
|
|
( |
|
|
|
( |
( |
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
Long-term debt |
|
|
( |
|
|
|
( |
|
( |
|
|
|
( |
( |
|
( |
|||||||||||||||||
of which structured notes over one year and up to two years |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which structured notes over two years |
|
|
( |
|
|
|
( |
|
( |
|
|
|
( |
( |
|
( |
|||||||||||||||||
of which high-trigger instruments |
|
|
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which other subordinated bonds |
|
|
|
|
|
|
|
|
|
|
|
( |
|
( |
|
|
|||||||||||||||||
of which non-recourse liabilities |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Other liabilities |
|
|
( |
|
( |
|
( |
( |
( |
|
|
|
|
( |
|
|
|||||||||||||||||
Total liabilities at fair value |
|
|
( |
|
( |
|
( |
|
( |
( |
|
|
( |
( |
|
|
|||||||||||||||||
Net assets/(liabilities) at fair value |
( |
|
|
|
( |
( |
|
( |
|
|
( |
( |
|
( |
|
|
|||||||||||||||||
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in
unrealized (gains)/losses on total liabilities at fair value relating to assets and
liabilities held at period end are included in net revenues or accumulated other comprehensive
income. As of 6M20, changes in net unrealized gains/(losses) of CHF
|
|||||||||||||||||||||||||||||||||
2
Includes an adjustment of CHF
|
Trading revenues |
Other revenues |
Accumulated other
comprehensive income |
|||||||||||||||||||||||||||||||
6M19 |
Balance at beginning of period |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
Settlements |
On transfers out |
On all other |
On transfers out |
On all other |
On transfers out |
On all other |
Foreign
currency translation impact |
Balance at end of period |
Changes in unrealized gains/losses |
1 | ||||||||||||||||
Assets (CHF million) | |||||||||||||||||||||||||||||||||
Securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Trading assets |
|
|
( |
|
( |
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which debt securities |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which foreign governments |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which corporates |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which RMBS |
|
|
( |
|
( |
|
|
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which equity securities |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|
( |
|||||||||||||||||
of which derivatives |
|
|
( |
|
|
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which interest rate products |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which foreign exchange derivatives |
|
|
( |
|
|
|
( |
|
( |
|
|
|
|
( |
|
( |
|||||||||||||||||
of which equity/index-related products |
|
|
( |
|
|
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which credit derivatives |
|
|
( |
|
|
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which other derivatives |
|
|
|
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which other trading assets |
|
|
( |
|
( |
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
Other investments |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which life finance instruments |
|
|
|
|
( |
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Loans |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which commercial and industrial loans |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which financial institutions |
|
|
|
|
( |
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which real estate |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Other intangible assets (mortgage servicing rights) |
|
|
|
|
|
|
|
|
|
|
( |
|
|
( |
|
( |
|||||||||||||||||
Other assets |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which loans held-for-sale |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Total assets at fair value |
|
|
( |
|
( |
|
( |
( |
|
|
( |
|
|
( |
|
|
|||||||||||||||||
Liabilities (CHF million) | |||||||||||||||||||||||||||||||||
Customer deposits |
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Obligation to return securities received as collateral |
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Trading liabilities |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which debt securities |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
of which equity securities |
|
|
|
|
( |
|
|
|
( |
|
|
|
|
|
|
|
|||||||||||||||||
of which derivatives |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which interest rate derivatives |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which foreign exchange derivatives |
|
|
( |
|
|
|
( |
( |
( |
|
|
|
|
|
|
( |
|||||||||||||||||
of which equity/index-related derivatives |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which credit derivatives |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Short-term borrowings |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Long-term debt |
|
|
2 |
( |
|
|
|
2 |
( |
2 |
|
|
2 |
|
|
|
|
2 |
( |
|
|
||||||||||||
of which structured notes over one year and up to two years |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which structured notes over two years |
|
|
( |
|
|
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
of which high-trigger instruments |
|
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Other liabilities |
|
|
( |
|
( |
|
( |
( |
|
|
|
|
|
( |
|
|
|||||||||||||||||
Total liabilities at fair value |
|
|
( |
|
( |
|
( |
|
|
|
|
|
|
( |
|
|
|||||||||||||||||
Net assets/(liabilities) at fair value |
( |
( |
|
|
( |
( |
|
( |
( |
|
( |
( |
( |
|
( |
( |
2 | ||||||||||||||||
1
Changes in unrealized gains/(losses) on total assets at fair value and changes in
unrealized (gains)/losses on total liabilities at fair value relating to assets and
liabilities held at period end are included in net revenues. As of 6M19, changes in
net unrealized gains/(losses) of CHF
(
|
|||||||||||||||||||||||||||||||||
2
Prior period has been corrected.
|
end of 6M20 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Securities received as collateral |
|
– | – | – | – | – | |||||||
Trading assets |
|
||||||||||||
of which debt securities |
|
||||||||||||
of which foreign governments |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
of which corporates |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
( |
|
|
|||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Correlation, in % |
( |
|
|
|||||||
Gap risk, in % | 2 |
|
|
|
|||||||||
Recovery rate, in % |
|
|
|
||||||||||
Volatility, in % |
|
|
|
||||||||||
of which |
|
Vendor price | Price, in actuals |
|
|
|
|||||||
of which RMBS |
|
Discounted cash flow | Default rate, in % |
|
|
|
|||||||
Discount rate, in % |
|
|
|
||||||||||
Loss severity, in % |
|
|
|
||||||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which equity securities |
|
Vendor price | Price, in actuals |
|
|
|
|||||||
of which derivatives |
|
||||||||||||
of which interest rate products |
|
Option model | Correlation, in % |
( |
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
Volatility, in % |
( |
|
( |
||||||||||
Volatility skew, in % |
( |
|
( |
||||||||||
of which foreign exchange products |
|
Option model | Correlation, in % |
|
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which equity/index-related products |
|
Option model | Buyback probability, in % |
|
|
|
|||||||
Correlation, in % |
( |
|
|
||||||||||
Gap risk, in % | 2 |
|
|
|
|||||||||
Volatility, in % |
( |
|
|
||||||||||
of which credit derivatives |
|
||||||||||||
of which |
|
Discounted cash flow | Correlation, in % |
|
|
|
|||||||
Credit curve volatility, in % |
|
|
|
||||||||||
Credit spread, in bp |
|
|
|
||||||||||
Default rate, in % |
|
|
|
||||||||||
Discount rate, in % |
|
|
|
||||||||||
Funding spread, in bp |
|
|
|
||||||||||
Loss severity, in % |
|
|
|
||||||||||
Prepayment rate, in % |
|
|
|
||||||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which other derivatives |
|
Discounted cash flow | Market implied life expectancy, in years |
|
|
|
|||||||
Mortality rate, in % |
|
|
|
||||||||||
of which other trading assets |
|
||||||||||||
of which |
|
Discounted cash flow | Market implied life expectancy, in years |
|
|
|
|||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Mortality rate, in % |
|
|
|
|||||||
1
Weighted average is calculated based on the fair value of the instruments.
|
|||||||||||||
2
Risk of unexpected large declines in the underlying values occurring between collateral
settlement dates.
|
end of 6M20 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Other investments |
|
||||||||||||
of which other equity investments |
|
||||||||||||
of which |
|
Discounted cash flow | Discount rate, in % |
|
|
|
|||||||
Terminal growth rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Vendor price | Price, in actuals |
|
|
|
|||||||
of which life finance instruments |
|
Discounted cash flow | Market implied life expectancy, in years |
|
|
|
|||||||
Loans |
|
||||||||||||
of which commercial and industrial loans |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which financial institutions |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which government and public institutions |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
Other intangible assets (mortgage servicing rights) |
|
– | – | – | – | – | |||||||
Other assets |
|
||||||||||||
of which loans held-for-sale |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
Total level 3 assets at fair value |
|
||||||||||||
1
Weighted average is calculated based on the fair value of the instruments.
|
end of 2019 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Securities received as collateral |
|
– | – | – | – | – | |||||||
Trading assets |
|
||||||||||||
of which debt securities |
|
||||||||||||
of which foreign governments |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
of which corporates |
|
||||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Correlation, in % |
( |
|
|
|||||||
Gap risk, in % | 2 |
|
|
|
|||||||||
Volatility, in % |
|
|
|
||||||||||
of which RMBS |
|
Discounted cash flow | Default rate, in % |
|
|
|
|||||||
Discount rate, in % |
|
|
|
||||||||||
Loss severity, in % |
|
|
|
||||||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which equity securities |
|
Vendor price | Price, in actuals |
|
|
|
|||||||
of which derivatives |
|
||||||||||||
of which interest rate products |
|
Option model | Correlation, in % |
|
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
Volatility skew, in % |
( |
|
( |
||||||||||
of which foreign exchange products |
|
Option model | Correlation, in % |
|
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which equity/index-related products |
|
Option model | Buyback probability, in % |
|
|
|
|||||||
Correlation, in % |
( |
|
|
||||||||||
Gap risk, in % | 2 |
|
|
|
|||||||||
Volatility, in % |
|
|
|
||||||||||
of which credit derivatives |
|
||||||||||||
of which |
|
Discounted cash flow | Correlation, in % |
|
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
Default rate, in % |
|
|
|
||||||||||
Discount rate, in % |
|
|
|
||||||||||
Funding spread, in bp |
|
|
|
||||||||||
Loss severity, in % |
|
|
|
||||||||||
Prepayment rate, in % |
|
|
|
||||||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which other derivatives |
|
Discounted cash flow | Market implied life expectancy, in years |
|
|
|
|||||||
Mortality rate, in % |
|
|
|
||||||||||
of which other trading assets |
|
||||||||||||
of which |
|
Discounted cash flow | Market implied life expectancy, in years |
|
|
|
|||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Mortality rate, in % |
|
|
|
|||||||
1
Cash instruments are generally presented on a weighted average basis, while certain
derivative instruments either contain a combination of weighted averages and arithmetic
means of the related inputs or are presented on an arithmetic mean basis.
|
|||||||||||||
2
Risk of unexpected large declines in the underlying values occurring between collateral
settlement dates.
|
end of 2019 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Other investments |
|
||||||||||||
of which other equity investments |
|
||||||||||||
of which |
|
Discounted cash flow | Discount rate, in % |
|
|
|
|||||||
Terminal growth rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Vendor price | Price, in actuals |
|
|
|
|||||||
of which life finance instruments |
|
Discounted cash flow | Market implied life expectancy, in years |
|
|
|
|||||||
Loans |
|
||||||||||||
of which commercial and industrial loans |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which financial institutions |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which government and public institutions | 830 | ||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
Other intangible assets (mortgage servicing rights) |
|
– | – | – | – | – | |||||||
Other assets |
|
||||||||||||
of which loans held-for-sale |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
Total level 3 assets at fair value |
|
||||||||||||
1
Cash instruments are generally presented on a weighted average basis, while certain
derivative instruments either contain a combination of weighted averages and arithmetic
means of the related inputs or are presented on an arithmetic mean basis.
|
end of 6M20 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Customer deposits |
|
Option model | Correlation, in % |
( |
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
Mean revision, in % | 2 |
|
|
|
|||||||||
Obligation to return securities received as collateral |
|
– | – | – | – | – | |||||||
Trading liabilities |
|
||||||||||||
of which equity securities |
|
Vendor price | Price, in actuals |
|
|
|
|||||||
of which derivatives |
|
||||||||||||
of which interest rate derivatives |
|
Option model | Correlation, in % |
( |
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which foreign exchange derivatives |
|
||||||||||||
of which |
|
Discounted cash flow | Contingent probability, in % |
|
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
of which |
|
Option model | Correlation, in % |
|
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which equity/index-related derivatives |
|
Option model | Buyback probability, in % | 3 |
|
|
|
||||||
Correlation, in % |
( |
|
|
||||||||||
Volatility, in % |
( |
|
|
||||||||||
of which credit derivatives |
|
||||||||||||
of which |
|
Discounted cash flow | Correlation, in % |
|
|
|
|||||||
Credit curve volatility, in % |
|
|
|
||||||||||
Credit spread, in bp |
|
|
|
||||||||||
Default rate, in % |
|
|
|
||||||||||
Discount rate, in % |
|
|
|
||||||||||
Funding spread, in bp |
|
|
|
||||||||||
Loss severity, in % |
|
|
|
||||||||||
Prepayment rate, in % |
|
|
|
||||||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Correlation, in % |
|
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
1
Weighted average is calculated based on the fair value of the instruments.
|
|||||||||||||
2
Management's best estimate of the speed at which interest rates will revert to the
long-term average.
|
|||||||||||||
3
Estimate of the probability of structured notes being put back to the Bank at the
option of the investor over the remaining life of the financial instruments.
|
end of 6M20 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Short-term borrowings |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
( |
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Option model | Buyback probability, in % |
|
|
|
|||||||
Correlation, in % |
( |
|
|
||||||||||
Fund gap risk, in % | 2 |
|
|
|
|||||||||
Volatility, in % |
|
|
|
||||||||||
Long-term debt |
|
||||||||||||
of which structured notes over one year and up to two years |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
|
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Option model | Buyback probability, in % | 3 |
|
|
|
||||||
Correlation, in % |
( |
|
|
||||||||||
Fund gap risk, in % | 2 |
|
|
|
|||||||||
Volatility, in % |
|
|
|
||||||||||
of which structured notes over two years |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
( |
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Buyback probability, in % | 3 |
|
|
|
||||||
Correlation, in % |
( |
|
|
||||||||||
Gap risk, in % | 2 |
|
|
|
|||||||||
Mean reversion, in % | 4 |
( |
|
( |
|||||||||
Volatility, in % |
|
|
|
||||||||||
of which other subordinated bonds |
|
– | – | – | – | – | |||||||
of which non-recourse liabilities |
|
Market comparable | Price, in % |
|
|
|
|||||||
Other liabilities |
|
– | – | – | – | – | |||||||
Total level 3 liabilities at fair value |
|
||||||||||||
1
Weighted average is calculated based on the fair value of the instruments.
|
|||||||||||||
2
Risk of unexpected large declines in the underlying values occurring between collateral
settlement dates.
|
|||||||||||||
3
Estimate of the probability of structured notes being put back to the Bank at the
option of the investor over the remaining life of the financial instruments.
|
|||||||||||||
4
Management's best estimate of the speed at which interest rates will revert to the
long-term average.
|
end of 2019 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Customer deposits |
|
Option model | Correlation, in % |
|
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
Mean revision, in % | 2 |
|
|
|
|||||||||
Obligation to return securities received as collateral |
|
– | – | – | – | – | |||||||
Trading liabilities |
|
||||||||||||
of which equity securities |
|
Vendor price | Price, in actuals |
|
|
|
|||||||
of which derivatives |
|
||||||||||||
of which interest rate derivatives |
|
Option model | Correlation, in % |
|
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which foreign exchange derivatives |
|
||||||||||||
of which |
|
Discounted cash flow | Contingent probability, in % |
|
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Correlation, in % |
|
|
|
|||||||
Prepayment rate, in % |
|
|
|
||||||||||
of which equity/index-related derivatives |
|
Option model | Buyback probability, in % | 3 |
|
|
|
||||||
Correlation, in % |
( |
|
|
||||||||||
Volatility, in % |
|
|
|
||||||||||
of which credit derivatives |
|
||||||||||||
of which |
|
Discounted cash flow | Correlation, in % |
|
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
Default rate, in % |
|
|
|
||||||||||
Discount rate, in % |
|
|
|
||||||||||
Funding spread, in bp |
|
|
|
||||||||||
Loss severity, in % |
|
|
|
||||||||||
Prepayment rate, in % |
|
|
|
||||||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Correlation, in % |
|
|
|
|||||||
Credit spread, in bp |
|
|
|
||||||||||
1
Cash instruments are generally presented on a weighted average basis, while certain
derivative instruments either contain a combination of weighted averages and arithmetic
means of the related inputs or are presented on an arithmetic mean basis.
|
|||||||||||||
2
Management's best estimate of the speed at which interest rates will revert to the
long-term average.
|
|||||||||||||
3
Estimate of the probability of structured notes being put back to the Bank at the
option of the investor over the remaining life of the financial instruments.
|
end of 2019 |
Fair value |
Valuation
technique |
Unobservable
input |
Minimum
value |
Maximum
value |
Weighted
average |
1 | ||||||
CHF million, except where indicated | |||||||||||||
Short-term borrowings |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
( |
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Option model | Buyback probability, in % |
|
|
|
|||||||
Correlation, in % |
( |
|
|
||||||||||
Fund gap risk, in % | 2 |
|
|
|
|||||||||
Volatility, in % |
|
|
|
||||||||||
Long-term debt |
|
||||||||||||
of which structured notes over one year and up to two years |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
( |
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Option model | Buyback probability, in % | 3 |
|
|
|
||||||
Correlation, in % |
( |
|
|
||||||||||
Fund gap risk, in % | 2 |
|
|
|
|||||||||
Volatility, in % |
|
|
|
||||||||||
of which structured notes over two years |
|
||||||||||||
of which |
|
Discounted cash flow | Credit spread, in bp |
( |
|
|
|||||||
Recovery rate, in % |
|
|
|
||||||||||
of which |
|
Market comparable | Price, in % |
|
|
|
|||||||
of which |
|
Option model | Buyback probability, in % | 3 |
|
|
|
||||||
Correlation, in % |
( |
|
|
||||||||||
Gap risk, in % | 2 |
|
|
|
|||||||||
Mean reversion, in % | 4 |
( |
|
( |
|||||||||
Volatility, in % |
|
|
|
||||||||||
of which high-trigger instruments |
|
– | – | – | – | – | |||||||
of which other subordinated bonds |
|
– | – | – | – | – | |||||||
Other liabilities |
|
– | – | – | – | – | |||||||
Total level 3 liabilities at fair value |
|
||||||||||||
1
Cash instruments are generally presented on a weighted average basis, while certain
derivative instruments either contain a combination of weighted averages and arithmetic
means of the related inputs or are presented on an arithmetic mean basis.
|
|||||||||||||
2
Risk of unexpected large declines in the underlying values occurring between collateral
settlement dates.
|
|||||||||||||
3
Estimate of the probability of structured notes being put back to the Bank at the
option of the investor over the remaining life of the financial instruments.
|
|||||||||||||
4
Management's best estimate of the speed at which interest rates will revert to the
long-term average.
|
6M20 | 2019 | ||||||||||||
end of |
Aggregate
fair value |
Aggregate
unpaid principal |
Difference |
Aggregate
fair value |
Aggregate
unpaid principal |
Difference |
|||||||
Financial instruments (CHF million) | |||||||||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
|
|
|
|||||||
Loans |
|
|
( |
|
|
( |
|||||||
Other assets 1 |
|
|
( |
|
|
( |
|||||||
Due to banks and customer deposits |
( |
( |
( |
( |
( |
( |
|||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
( |
( |
|
( |
( |
|
|||||||
Short-term borrowings |
( |
( |
|
( |
( |
( |
|||||||
Long-term debt |
( |
( |
|
( |
( |
|
|||||||
Other liabilities |
( |
( |
|
( |
( |
|
|||||||
Non-performing and non-interest-earning loans 2 |
|
|
( |
|
|
( |
|||||||
1
Primarily loans held-for-sale.
|
|||||||||||||
2
Included in loans or other assets.
|
6M20 | 6M19 | ||||
in |
Net
gains/ (losses) |
Net
gains/ (losses) |
|||
Financial instruments (CHF million) | |||||
Interest-bearing deposits with banks |
|
1 |
|
1 | |
of which related to credit risk |
( |
|
|||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
1 |
|
1 | |
Other investments 2 |
|
3 |
|
3 | |
of which related to credit risk |
|
|
|||
Loans |
( |
3 |
|
1 | |
of which related to credit risk |
( |
|
|||
Other assets |
|
1 |
|
3 | |
of which related to credit risk |
( |
|
|||
Due to banks and customer deposits |
( |
3 |
( |
3 | |
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
( |
1 |
( |
1 | |
Short-term borrowings |
( |
3 |
( |
3 | |
of which related to credit risk |
|
|
|||
Long-term debt 2 |
|
3 |
( |
3 | |
of which related to credit risk |
|
|
|||
Other liabilities |
( |
3 |
|
4 | |
of which related to credit risk |
( |
|
|||
1
Primarily recognized in net interest income.
|
|||||
2
Prior period has been corrected.
|
|||||
3
Primarily recognized in trading revenues.
|
|||||
4
Primarily recognized in other revenues.
|
Gains/(losses) recorded into AOCI |
1 |
Gains/(losses) recorded
in AOCI transferred to net income |
1 | ||||||||
in | 6M20 | Cumulative | 6M19 | 6M20 | 6M19 | ||||||
Financial instruments (CHF million) | |||||||||||
Customer deposits |
|
( |
( |
|
|
||||||
Short-term borrowings |
( |
( |
|
|
|
||||||
Long-term debt |
|
( |
( |
|
|
||||||
of which treasury debt over two years |
|
|
( |
|
|
||||||
of which structured notes over two years |
|
( |
( |
|
|
||||||
Total |
|
( |
( |
|
|
||||||
1
Amounts are reflected gross of tax.
|
Carrying
value |
Fair value |
||||||||||
end of | Level 1 | Level 2 | Level 3 | Total | |||||||
6M20 (CHF million) | |||||||||||
Financial assets | |||||||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
|
|
||||||
Investment securities |
|
|
|
|
|
||||||
Loans |
|
|
|
|
|
||||||
Other financial assets 1 |
|
|
|
|
|
||||||
Financial liabilities | |||||||||||
Due to banks and customer deposits |
|
|
|
|
|
||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
|
|
||||||
Short-term borrowings |
|
|
|
|
|
||||||
Long-term debt |
|
|
|
|
|
||||||
Other financial liabilities 2 |
|
|
|
|
|
||||||
2019 (CHF million) | |||||||||||
Financial assets | |||||||||||
Central bank funds sold, securities purchased under resale agreements and securities borrowing transactions |
|
|
|
|
|
||||||
Loans |
|
|
|
|
|
||||||
Other financial assets 1 |
|
|
|
|
|
||||||
Financial liabilities | |||||||||||
Due to banks and customer deposits |
|
|
|
|
|
||||||
Central bank funds purchased, securities sold under repurchase agreements and securities lending transactions |
|
|
|
|
|
||||||
Short-term borrowings |
|
|
|
|
|
||||||
Long-term debt |
|
|
|
|
|
||||||
Other financial liabilities 2 |
|
|
|
|
|
||||||
1
Primarily includes cash and due from banks, interest-bearing deposits with banks,
loans held-for-sale, cash collateral on derivative instruments, interest and fee receivables
and non-marketable equity securities.
|
|||||||||||
2
Primarily includes cash collateral on derivative instruments and interest and fee
payables.
|
end of | 6M20 | 2019 | |||
CHF million | |||||
Total assets pledged or assigned as collateral |
|
|
|||
of which encumbered |
|
|
end of | 6M20 | 2019 | |||
CHF million | |||||
Fair value of collateral received with the right to sell or repledge |
|
|
|||
of which sold or repledged |
|
|